Background and aims The pharmacotherapy of diabetes mellitus has a colossal economic
burden, which demands cost-effective therapy, as the patients have to be on treatment …

Real‐world evidence (RWE) is emerging as a fundamental component of the post‐
marketing evaluation of medicinal products. Even though the focus on RWE studies has …

Background Type 2 diabetes mellitus is one of the most common causes of chronic kidney
disease (CKD) worldwide and prevalence of 1.75 per 100 inhabitants in Colombia. The aim …

The excess risk of cancer observed in patients with type 2 diabetes (T2DM) may have been
influenced by detection bias. The aim of this study was to examine the real association by …

Materials and Methods: Study of drug consumption was conducted using anatomical
therapeutic chemical/defined daily dose (ATC/DDD) methodology by calculating such …

Background Type 2 diabetes mellitus (T2DM) greatly increases cardiovascular risk. Primary
and secondary cardiovascular prevention lead to lower cardiovascular events, improved …

Aims. To determine the time elapsed from when a patient≥ 65 years old is diagnosed with
type 2 diabetes mellitus (T2DM) and begins antidiabetic treatment until a change in …

Universidad Autónoma del Estado de Morelos Page 1 Universidad Autónoma del Estado de
Morelos Facultad de Farmacia Análisis de las enfermedades crónicas y sus tratamientos …

La Revista Española de Nutrición Humana y Dietética se esfuerza por mantener a un
sistema de publicación continua, de modo que los artículos se publican antes de su formato …

i ESSAYS ON PHYSICIAN AND PATIENT BEHAVIOUR: ADHERENCE, ADOPTION AND
DIFFUSION OF ANTIDIABETIC PHARMACEUTICALS by Joana Patríci Page 1 i ESSAYS ON …